Investor mix
17 investors on record; lead investors include ID Ventures, Atinum Investment, SBI Investment Korea, DT&Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 47% |
| Private equity | 2 | 12% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 35% |
Developer of exosome-based therapeutics for regenerative medicine
17 investors on record; lead investors include ID Ventures, Atinum Investment, SBI Investment Korea, DT&Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 47% |
| Private equity | 2 | 12% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 35% |